Journal of Neuroinflammation

Article	Citations
Correction: Smek1 deficiency exacerbates experimental autoimmune encephalomyelitis by activating proinflammatory microglia and suppressing the IDO1-AhR pathway	425
Fractalkine isoforms differentially regulate microglia-mediated inflammation and enhance visual function in the diabetic retina	319
Regulation of the p75 neurotrophin receptor attenuates neuroinflammation and stimulates hippocampal neurogenesis in experimental Streptococcus pneumoniae meningitis	296
Correction to: Vagus nerve stimulation modulates hippocampal inflammation caused by continuous stress in rats	279
Intrauterine inflammation and postnatal intravenous dopamine alter the neurovascular unit in preterm newborn lambs	239
Extracellular vesicles produced by HIV-1 Nef-expressing cells induce myelin impairment and oligodendrocyte damage in the mouse central nervous system	196
Argonaute-2 protects the neurovascular unit from damage caused by systemic inflammation	176
Inhibition of neutrophil extracellular traps alleviates blood–brain barrier disruption and cognitive dysfunction via Wnt3/β-catenin/TCF4 signaling in sepsis-associated encephalopathy	166
HIF1α-dependent hypoxia response in myeloid cells requires IRE1α	154
Zika virus infection of mature neurons from immunocompetent mice generates a disease-associated microglia and a tauopathy-like phenotype in link with a delayed interferon beta response	153
Correction to: Pharmacologic activation of cholinergic alpha7 nicotinic receptors mitigates depressive-like behavior in a mouse model of chronic stress	153
Carotid artery vascular stenosis causes the blood-CSF barrier damage and neuroinflammation	149
IL-7Rα on CD4+ T cells is required for their survival and the pathogenesis of experimental autoimmune encephalomyelitis	147
The deficient CLEC5A ameliorates the behavioral and pathological deficits via the microglial Aβ clearance in Alzheimer’s disease mouse model	141
Preoperative gut microbiota of POCD patients induces pre- and postoperative cognitive impairment and systemic inflammation in rats	137
Macrophage elastase (MMP12) critically contributes to the development of subretinal fibrosis	128
The associations between plasma soluble Trem1 and neurological diseases: a Mendelian randomization study	126
Maternal immunoglobulin G affects brain development of mouse offspring	125
Integrin Mac1 mediates paraquat and maneb-induced learning and memory impairments in mice through NADPH oxidase–NLRP3 inflammasome axis-dependent microglial activation	123
TPM1 mediates inflammation downstream of TREM2 via the PKA/CREB signaling pathway	120
Flow cytometry identifies changes in peripheral and intrathecal lymphocyte patterns in CNS autoimmune disorders and primary CNS malignancies	119
Brain gray matter astroglia-specific connexin 43 ablation attenuates spinal cord inflammatory demyelination	117
Phosphatidate phosphatase Lipin1 alters mitochondria-associated endoplasmic reticulum membranes (MAMs) homeostasis: effects which contribute to the development of diabetic encephalopathy	102
Citrobacter rodentium infection impairs dopamine metabolism and exacerbates the pathology of Parkinson’s disease in mice	100
Therapeutic intervention in neuroinflammation for neovascular ocular diseases through targeting the cGAS-STING-necroptosis pathway	91

Inhibition of histone deacetylase 6 alleviates neuropathic pain via direct regulating post-translation of spinal STAT3 and decreasing downstream C-C Motif Chemokine Ligand 7 synthesis	90
Microglia-derived exosomes modulate myelin regeneration via miR-615-5p/MYRF axis	89
Red nucleus IL-33 facilitates the early development of mononeuropathic pain in male rats by inducing TNF-α through activating ERK, p38 MAPK, and JAK2/STAT3	87
How the gut microbiota impacts neurodegenerative diseases by modulating CNS immune cells	87
LXR agonism for CNS diseases: promises and challenges	83
Selective neuronal expression of progranulin is sufficient to provide neuroprotective and anti-inflammatory effects after traumatic brain injury	83
Stroke-induced immunosuppression: implications for the prevention and prediction of post-stroke infections	80
Tregs dysfunction aggravates postoperative cognitive impairment in aged mice	80
HMGB1 mediates synaptic loss and cognitive impairment in an animal model of sepsis-associated encephalopathy	79
Exercise suppresses neuroinflammation for alleviating Alzheimer’s disease	78
Marine fungal metabolite butyrolactone I prevents cognitive deficits by relieving inflammation and intestinal microbiota imbalance on aluminum trichloride-injured zebrafish	78
Traumatic brain injury results in unique microglial and astrocyte transcriptomes enriched for type I interferon response	77
Tryptophan-kynurenine metabolism: a link between the gut and brain for depression in inflammatory bowel disease	76
Protein kinase B (AKT) upregulation and Thy-1-αvβ3 integrin-induced phosphorylation of Connexin43 by activated AKT in astrogliosis	75
Exogenous monocyte myeloid-derived suppressor cells ameliorate immune imbalance, neuroinflammation and cognitive impairment in 5xFAD mice infected with Porphyromonas gingivalis	75
α7 Nicotinic acetylcholine receptor: a key receptor in the cholinergic anti-inflammatory pathway exerting an antidepressant effect	74
Injection of amyloid-β to lateral ventricle induces gut microbiota dysbiosis in association with inhibition of cholinergic anti-inflammatory pathways in Alzheimer’s disease	74
Macrophage exosomal miR-30c-2-3p in atherosclerotic plaques aggravates microglial neuroinflammation during large-artery atherosclerotic stroke via TGF-β/SMAD2 pathway	73
Intracranial VCAM1 at time of mechanical thrombectomy predicts ischemic stroke severity	73
Immune response and pathogen invasion at the choroid plexus in the onset of cerebral toxoplasmosis	73
Remibrutinib (LOU064) inhibits neuroinflammation driven by B cells and myeloid cells in preclinical models of multiple sclerosis	72
Innate immune sensors and regulators at the blood brain barrier: focus on toll-like receptors and inflammasomes as mediators of neuro-immune crosstalk and inflammation	72
MicroRNA-155-5p promotes neuroinflammation and central sensitization via inhibiting SIRT1 in a nitroglycerin-induced chronic migraine mouse model	72
AIBP controls TLR4 inflammarafts and mitochondrial dysfunction in a mouse model of Alzheimer’s disease	72
TLR4-dependent neuroinflammation mediates LPS-driven food-reward alterations during high-fat exposure	71
Supporting the differential diagnosis of connective tissue diseases with neurological involvement by blood and cerebrospinal fluid flow cytometry	70
Profiling the neuroimmune cascade in 3xTg-AD mice exposed to successive mild traumatic brain injuries	70
H3K27me3 of Rnf19a promotes neuroinflammatory response during Japanese encephalitis virus infection	70
Immunotherapy with an antibody against CD1d modulates neuroinflammation in an α-synuclein transgenic model of Lewy body like disease	69
Single-cell RNA sequencing reveals peripheral blood leukocyte responses to spinal cord injury in mice with humanised immune systems	69
Sequential treatment with a TNFR2 agonist and a TNFR1 antagonist improves outcomes in a humanized mouse model for MS	69
Chronic rapid eye movement sleep deprivation aggravates the pathogenesis of Alzheimer’s disease by decreasing brain O-GlcNAc cycling in mice	68
Deterioration of neuroimmune homeostasis in Alzheimer’s Disease patients who survive a COVID-19 infection	68
NLRX1 limits inflammatory neurodegeneration in the anterior visual pathway	67
Correction: Hydrogen sulfide-releasing cyclooxygenase inhibitor ATB-346 enhances motor function and reduces cortical lesion volume following traumatic brain injury in mice	66
Inflammasomes at the crossroads of traumatic brain injury and post-traumatic epilepsy	66
IDO1 modulates pain sensitivity and comorbid anxiety in chronic migraine through microglial activation and synaptic pruning	66
Decoding Behcet’s Uveitis: an In-depth review of pathogenesis and therapeutic advances	65
miR-19a/b-3p promotes inflammation during cerebral ischemia/reperfusion injury via SIRT1/FoxO3/SPHK1 pathway	64
Compromised endothelial Wnt/β-catenin signaling mediates the blood-brain barrier disruption and leads to neuroinflammation in endotoxemia	64
Nanoparticulate MgH2 ameliorates anxiety/depression-like behaviors in a mouse model of multiple sclerosis by regulating microglial polarization and oxidative stress	63
Role of lipocalin-2 in surgery-induced cognitive decline in mice: a signal from neuron to microglia	62
Long-term running exercise improves cognitive function and promotes microglial glucose metabolism and morphological plasticity in the hippocampus of APP/PS1 mice	61
Hypochlorous acid derived from microglial myeloperoxidase could mediate high-mobility group box 1 release from neurons to amplify brain damage in cerebral ischemia–reperfusion injury	60
Ubiquitination-mediated upregulation of glycolytic enzyme MCT4 in promoting astrocyte reactivity during neuroinflammation	60
Distinguishing the effects of systemic CSF1R inhibition by PLX3397 on microglia and peripheral immune cells	60
Nisin a probiotic bacteriocin mitigates brain microbiome dysbiosis and Alzheimer’s disease-like neuroinflammation triggered by periodontal disease	60
Febrile temperature-regulated TRPV1 in CD4+ T cells mediates neuroinflammation in complex febrile seizures	60
CSF sTREM2 in neurological diseases: a two-sample Mendelian randomization study	59
The multifaceted role of vitreous hyalocytes: Orchestrating inflammation, angiomodulation and erythrophagocytosis in proliferative diabetic retinopathy	59

The interaction between central and peripheral immune systems in methamphetamine use disorder: current status and future directions	59
Complement inhibition targets a rich-club within the neuroinflammatory network after stroke to improve radiographic and functional outcomes	59
Cladribine treatment improves cortical network functionality in a mouse model of autoimmune encephalomyelitis	58
Human PMSCs-derived small extracellular vesicles alleviate neuropathic pain through miR-26a-5p/Wnt5a in SNI mice model	58
Crosstalk between astrocytes and microglia results in increased degradation of α-synuclein and amyloid-β aggregates	57
Interleukin-3 is associated with sTREM2 and mediates the correlation between amyloid-β and tau pathology in Alzheimer’s disease	57
CXCR5 down-regulation alleviates cognitive dysfunction in a mouse model of sepsis-associated encephalopathy: potential role of microglial autophagy and the p38MAPK/NF-κB/STAT3 signaling pathway	56
Extracellular vesicles from mesenchymal stem cells reduce neuroinflammation in hippocampus and restore cognitive function in hyperammonemic rats	56
Dimethyl fumarate improves cognitive impairment and neuroinflammation in mice with Alzheimer’s disease	55
GAS6 as a potential target to alleviate neuroinflammation during Japanese encephalitis in mouse models	55
TRPV4 contributes to ER stress and inflammation: implications for Parkinson’s disease	55
Mitochondrial DNA leakage: underlying mechanisms and therapeutic implications in neurological disorders	55
Biologic TNF-α inhibitors reduce microgliosis, neuronal loss, and tau phosphorylation in a transgenic mouse model of tauopathy	55
Hepcidin deficiency impairs hippocampal neurogenesis and mediates brain atrophy and memory decline in mice	54
Inhibition of UTX/KDM6A improves recovery of spinal cord injury by attenuating BSCB permeability and macrophage infiltration through the MLCK/p-MLC pathway	54
Tryptophan-rich diet and its effects on Htr7+ Tregs in alleviating neuroinflammation and cognitive impairment induced by lipopolysaccharide	54
Brain transcriptome analysis of a CLN2 mouse model as a function of disease progression	54
Prolactin deficiency drives diabetes-associated cognitive dysfunction by inducing microglia-mediated synaptic loss	53
4-Ethylguaiacol modulates neuroinflammation and Th1/Th17 differentiation to ameliorate disease severity in experimental autoimmune encephalomyelitis	53
Inflammatory monocytes and microglia play independent roles in inflammatory ictogenesis	52
Appearance of claudin-5+ leukocyte subtypes in the blood and CNS during progression of EAE	52
Absence of the lectin-like domain of thrombomodulin reduces HSV-1 lethality of mice with increased microglia responses	52
Traumatic brain injury alters the effects of class II invariant peptide (CLIP) antagonism on chronic meningeal CLIP + B cells, neuropathology, and neurobehavioral impairment in 5xFAD mice	52
Exploratory analysis of a Novel RACK1 mutation and its potential role in epileptic seizures via Microglia activation	50
APOEε4 alters ApoE and Fabp7 in frontal cortex white matter in prodromal Alzheimer's disease	50
Integration of National Health Insurance claims data and animal models reveals fexofenadine as a promising repurposed drug for Parkinson’s disease	50
Satellite microglia: marker of traumatic brain injury and regulator of neuronal excitability	50
Pericytes are protective in experimental pneumococcal meningitis through regulating leukocyte infiltration and blood–brain barrier function	49
High-fat diet-induced diabetes leads to vascular alterations, pericyte reduction, and perivascular depletion of microglia in a 6-OHDA toxin model of Parkinson disease	49
TYROBP/DAP12 knockout in Huntington’s disease Q175 mice cell-autonomously decreases microglial expression of disease-associated genes and non-cell-autonomously mitigates astrogliosis and motor deterio	49
The BET PROTAC inhibitor dBET6 protects against retinal degeneration and inhibits the cGAS-STING in response to light damage	48
Repurposing of epalrestat for neuroprotection in parkinson’s disease via activation of the KEAP1/Nrf2 pathway	48
Annexin A1 protects against cerebral ischemia–reperfusion injury by modulating microglia/macrophage polarization via FPR2/ALX-dependent AMPK-mTOR pathway	48
Rifaximin-mediated gut microbiota regulation modulates the function of microglia and protects against CUMS-induced depression-like behaviors in adolescent rat	48
Morinda officinalis oligosaccharides mitigate depression-like behaviors in hypertension rats by regulating Mfn2-mediated mitophagy	48
Fenebrutinib, a Bruton’s tyrosine kinase inhibitor, blocks distinct human microglial signaling pathways	47
Astrocytic stress response is induced by exposure to astrocyte-binding antibodies expressed by plasmablasts from pediatric patients with acute transverse myelitis	47
Soluble CD27 is an intrathecal biomarker of T-cell-mediated lesion activity in multiple sclerosis	47
The insular cortex is not insular in thyroid eye disease: neuroimaging revelations of central–peripheral system interaction	47
Sex differences and similarities in the neuroimmune response to central administration of poly I:C	46
Microglial–oligodendrocyte interactions in myelination and neurological function recovery after traumatic brain injury	46
Asrij/OCIAD1 depletion reduces inflammatory microglial activation and ameliorates Aβ pathology in an Alzheimer’s disease mouse model	46
Prostaglandin EP2 receptor antagonist ameliorates neuroinflammation in a two-hit mouse model of Alzheimer’s disease	46
Therapeutic reduction of neurocan in murine intracerebral hemorrhage lesions promotes oligodendrogenesis and functional recovery	46
Transient post-operative overexpression of CXCR2 on monocytes of traumatic brain injury patients drives monocyte chemotaxis toward cerebrospinal fluid and enhances monocyte-mediated immunogenic cell d	46
Retraction Note to: Regulation of autophagy by the nuclear factor κB signaling pathway in the hippocampus of rats with sepsis	45
Neuroprotective effects of GSK-343 in an in vivo model of MPTP-induced nigrostriatal degeneration	45
Cinnamaldehyde and its combination with deferoxamine ameliorate inflammation, ferroptosis and hematoma expansion after intracerebral hemorrhage in mice	44
Neuroinflammatory transcriptional programs induced in rhesus pre-frontal cortex white matter during acute SHIV infection	44
Calcitonin gene-related peptide regulates spinal microglial activation through the histone H3 lysine 27 trimethylation via enhancer of zeste homolog-2 in rats with neuropathic pain	44
25-Hydroxycholesterol modulates microglial function and exacerbates Alzheimer’s disease pathology: mechanistic insights and therapeutic potential of cholesterol esterification inhibition	44
Proteomic profiling identifies novel inflammation-related plasma proteins associated with ischemic stroke outcome	44
Impact of disease-modifying therapy on dendritic cells and exploring their immunotherapeutic potential in multiple sclerosis	43
Transfer of patient’s peripheral blood mononuclear cells (PBMCs) disrupts blood–brain barrier and induces anti-NMDAR encephalitis: a study of novel humanized PBMC mouse model	43
Upregulation of TRPC5 in hippocampal excitatory synapses improves memory impairment associated with neuroinflammation in microglia knockout IL-10 mice	42
Inflammasome inhibition protects dopaminergic neurons from α-synuclein pathology in a model of progressive Parkinson’s disease	42
SRGN amplifies microglia-mediated neuroinflammation and exacerbates ischemic brain injury	41
Mild-to-severe traumatic brain injury in children: altered cytokines reflect severity	41
Ogt-mediated O-GlcNAcylation inhibits astrocytes activation through modulating NF-κB signaling pathway	41
Extended interval dosing of ocrelizumab modifies the repopulation of B cells without altering the clinical efficacy in multiple sclerosis	40
Noninvasive ultrasound stimulation to treat myocarditis through splenic neuro-immune regulation	40
The glucocorticoid receptor as a master regulator of the Müller cell response to diabetic conditions in mice	40
Single-cell RNA sequencing reveals a landscape and targeted treatment of ferroptosis in retinal ischemia/reperfusion injury	40
An AGS-associated mutation in ADAR1 catalytic domain results in early-onset and MDA5-dependent encephalopathy with IFN pathway activation in the brain	40
Elevated lipoprotein(a) and lipoprotein-associated phospholipase A2 are associated with unfavorable functional outcomes in patients with ischemic stroke	40
Hydroxychloroquine attenuates neuroinflammation following traumatic brain injury by regulating the TLR4/NF-κB signaling pathway	40
[18F]F-DED PET imaging of reactive astrogliosis in neurodegenerative diseases: preclinical proof of concept and first-in-human data	40
Targeting neuroinflammation as a preventive and therapeutic approach for perioperative neurocognitive disorders	39
Group 2 innate lymphoid cells are numerically and functionally deficient in the triple transgenic mouse model of Alzheimer’s disease	39
Serum GFAP and NfL as disease severity and prognostic biomarkers in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder	39
Ethanol-activated microglial exosomes induce MCP1 signaling mediated death of stress-regulatory proopiomelanocortin neurons in the developing hypothalamus	39
25-hydroxycholesterol promotes brain cytokine production and leukocyte infiltration in a mouse model of lipopolysaccharide-induced neuroinflammation	38
Sitagliptin eye drops prevent the impairment of retinal neurovascular unit in the new Trpv2+/− rat model	38
Transcriptomic analysis unveils bona fide molecular signatures of microglia under conditions of homeostasis and viral encephalitis	38
Central activation of the fatty acid sensor GPR120 suppresses microglia reactivity and alleviates sickness- and anxiety-like behaviors	38
Fidgetin-like 2 knockdown increases acute neuroinflammation and improves recovery in a rat model of spinal cord injury	38
Supraphysiologic doses of 17β-estradiol aggravate depression-like behaviors in ovariectomized mice possibly via regulating microglial responses and brain glycerophospholipid metabolism	38
Impairment of neuronal tyrosine phosphatase STEP worsens post-ischemic inflammation and brain injury under hypertensive condition	38
Temporal changes in regulatory T cell subsets defined by the transcription factor Helios in stroke and their potential role in stroke-associated infection: a prospective case–control study	38
PARP9 exacerbates apoptosis and neuroinflammation via the PI3K pathway in the thalamus and hippocampus and cognitive decline after cortical infarction	38

MAVS signaling shapes microglia responses to neurotropic virus infection	38
The contribution of the meningeal immune interface to neuroinflammation in traumatic brain injury	38
Lowering blood cholesterol does not affect neuroinflammation in experimental autoimmune encephalomyelitis	38
Effects of diabetes on microglial physiology: a systematic review of in vitro, preclinical and clinical studies	38
RhANP attenuates endotoxin-derived cognitive dysfunction through subdiaphragmatic vagus nerve-mediated gut microbiota–brain axis	38
Aicardi-Goutières syndrome-associated mutation at ADAR1 gene locus activates innate immune response in mouse brain	37
Erythrocyte–brain endothelial interactions induce microglial responses and cerebral microhemorrhages in vivo	37
Soluble TREM2 is associated with death and cardiovascular events after acute ischemic stroke: an observational study from CATIS	37
Impaired response of blood neutrophils to cell-death stimulus differentiates AQP4-IgG-seropositive NMOSD from MOGAD	37
Administration of Maresin-1 ameliorates the physiopathology of experimental autoimmune encephalomyelitis	37
IL-10 production by granulocytes promotes Staphylococcus aureus craniotomy infection	37
Transcriptome alterations in peripheral blood B cells of patients with multiple sclerosis receiving immune reconstitution therapy	37
Neuroimmune multi-hit perspective of coronaviral infection	37
Type I/type III IFN and related factors regulate JEV infection and BBB endothelial integrity	37
Interleukin-6 actions in the hypothalamus protects against obesity and is involved in the regulation of neurogenesis	36
Intermittent theta-burst stimulation improves motor function by inhibiting neuronal pyroptosis and regulating microglial polarization via TLR4/NFκB/NLRP3 signaling pathway in cerebral ischemic mice	36
Neuroinflammation, memory, and depression: new approaches to hippocampal neurogenesis	36
Cyanidin-3-O-glucoside protects the brain and improves cognitive function in APPswe/PS1ΔE9 transgenic mice model	36
Homer1 promotes the conversion of A1 astrocytes to A2 astrocytes and improves the recovery of transgenic mice after intracerebral hemorrhage	36
Reduced microglia activation following metformin administration or microglia ablation is sufficient to prevent functional deficits in a mouse model of neonatal stroke	36
TAK1 mediates neuronal pyroptosis in early brain injury after subarachnoid hemorrhage	35
High-parameter cytometry unmasks microglial cell spatio-temporal response kinetics in severe neuroinflammatory disease	35
TRPV4-induced Müller cell gliosis and TNF-α elevation-mediated retinal ganglion cell apoptosis in glaucomatous rats via JAK2/STAT3/NF-κB pathway	35
Role of SPAK–NKCC1 signaling cascade in the choroid plexus blood–CSF barrier damage after stroke	35
Inhibition of discoidin domain receptor (DDR)-1 with nilotinib alters CSF miRNAs and is associated with reduced inflammation and vascular fibrosis in Alzheimer’s disease	34
Impact of noradrenergic inhibition on neuroinflammation and pathophysiology in mouse models of Alzheimer’s disease	34
Microglia sustain anterior cingulate cortex neuronal hyperactivity in nicotine-induced pain	34
Deletion of CD47 from Schwann cells and macrophages hastens myelin disruption/dismantling and scavenging in Schwann cells and augments myelin debris phagocytosis in macrophages	34
Neuroimmune proteins can differentiate between tauopathies	34
Morphine-induced microglial immunosuppression via activation of insufficient mitophagy regulated by NLRX1	34
The novel HS-mimetic, Tet-29, regulates immune cell trafficking across barriers of the CNS during inflammation	34
Correction to: Cathepsin C promotes microglia M1 polarization and aggravates neuroinflammation via activation of Ca2+-dependent PKC/p38MAPK/NF-κB pathway	34
Microglia and Immune cells interactions in multiple sclerosis cognitive impairment: a postmortem study	34
Role of myeloid cells in ischemic retinopathies: recent advances and unanswered questions	34
P2X7 receptor antagonists modulate experimental autoimmune neuritis via regulation of NLRP3 inflammasome activation and Th17 and Th1 cell differentiation	33
Global gene expression and chromatin accessibility of the peripheral nervous system in animal models of persistent pain	33
Moss-derived human complement factor H modulates retinal immune response and attenuates retinal degeneration	33
Integrated single-cell transcriptomics of cerebrospinal fluid cells in treatment-naïve multiple sclerosis	33
Longitudinal cerebrospinal fluid measurements show glial hypo- and hyperactivation in predementia Alzheimer’s disease	33
Western diet increases brain metabolism and adaptive immune responses in a mouse model of amyloidosis	33
Interleukin-6 deficiency reduces neuroinflammation by inhibiting the STAT3-cGAS-STING pathway in Alzheimer’s disease mice	32
Interleukin-9 protects from microglia- and TNF-mediated synaptotoxicity in experimental multiple sclerosis	32
Systemic inflammation alters the neuroinflammatory response: a prospective clinical trial in traumatic brain injury	32
Repeated LPS induces training and tolerance of microglial responses across brain regions	32
Ambient RNAs removal of cortex-specific snRNA-seq reveals Apoe+ microglia/macrophage after deeper cerebral hypoperfusion in mice	32
Phthalide derivative CD21 attenuates tissue plasminogen activator-induced hemorrhagic transformation in ischemic stroke by enhancing macrophage scavenger receptor 1-mediated DAMP (peroxiredoxin 1) cle	32
Neurofilament light: a possible prognostic biomarker for treatment of vascular contributions to cognitive impairment and dementia	32
Fatty acids role in multiple sclerosis as “metabokines”	32
Models of microglia depletion and replenishment elicit protective effects to alleviate vascular and neuronal damage in the diabetic murine retina	32
N-acetylglucosamine inhibits inflammation and neurodegeneration markers in multiple sclerosis: a mechanistic trial	32
HMGB1 mediates cognitive impairment caused by the NLRP3 inflammasome in the late stage of traumatic brain injury	32
Fascin-1 limits myosin activity in microglia to control mechanical characterization of the injured spinal cord	32
NAD+ improves cognitive function and reduces neuroinflammation by ameliorating mitochondrial damage and decreasing ROS production in chronic cerebral hypoperfusion models through Sirt1/PGC-1α pathway	31
Acute postnatal inflammation alters adult microglial responses to LPS that are sex-, region- and timing of postnatal inflammation-dependent	31
Activation of GPR40 attenuates neuroinflammation and improves neurological function via PAK4/CREB/KDM6B pathway in an experimental GMH rat model	31
Divanillyl sulfone suppresses NLRP3 inflammasome activation via inducing mitophagy to ameliorate chronic neuropathic pain in mice	31
Inhibition of NADPH oxidase 2 enhances resistance to viral neuroinflammation by facilitating M1-polarization of macrophages at the extraneural tissues	31
Up-regulated succinylation modifications induce a senescence phenotype in microglia by altering mitochondrial energy metabolism	31
Differential contribution of THIK-1 K+ channels and P2X7 receptors to ATP-mediated neuroinflammation by human microglia	31
Perivascular macrophages in high-fat diet-induced hypothalamic inflammation	31
Hippocampal microRNA-26a-3p deficit contributes to neuroinflammation and behavioral disorders via p38 MAPK signaling pathway in rats	30
Synergistic effects of repeated transcranial magnetic stimulation and mesenchymal stem cells transplantation on alleviating neuroinflammation and PANoptosis in cerebral ischemia	30
Innate immune stimulation by monophosphoryl lipid A prevents chronic social defeat stress-induced anxiety-like behaviors in mice	30
SPOCK2 modulates neuropathic pain by interacting with MT1-MMP to regulate astrocytic MMP-2 activation in rats with chronic constriction injury	30
Aberrant copper metabolism and hepatic inflammation cause neurological manifestations in a mouse model of Wilson’s disease	30
1α,25-dihydroxyvitamin D3 protects retinal ganglion cells in glaucomatous mice	30
Distinct features of B cell receptors in neuromyelitis optica spectrum disorder among CNS inflammatory demyelinating diseases	29
Glyceryl triacetate promotes blood–brain barrier recovery after ischemic stroke through lipogenesis-mediated IL-33 in mice	29
Astroglial modulation of synaptic function in the non-demyelinated cerebellar cortex is dependent on MyD88 signaling in a model of toxic demyelination	29
The interaction of tPA with NMDAR1 drives neuroinflammation and neurodegeneration in α-synuclein-mediated neurotoxicity	29
Biomass smoke inhalation promotes neuroinflammatory and metabolomic temporal changes in the hippocampus of female mice	29
H3K18 lactylation-mediated nucleotide-binding oligomerization domain-2 (NOD2) expression promotes bilirubin-induced pyroptosis of astrocytes	29
Growth differentiation factor 15 aggravates sepsis-induced cognitive and memory impairments by promoting microglial inflammatory responses and phagocytosis	29
Japanese encephalitis virus-induced DNA methylation contributes to blood-brain barrier permeability by modulating tight junction protein expression	28
Endothelial glycocalyx in traumatic brain injury associated coagulopathy: potential mechanisms and impact	28
Autophagy protein NRBF2 attenuates endoplasmic reticulum stress-associated neuroinflammation and oxidative stress via promoting autophagosome maturation by interacting with Rab7 after SAH	28
Neuroimmune modulation in liver pathophysiology	28
Mitochondrial protective effects caused by the administration of mefenamic acid in sepsis	28
Mas receptor activation facilitates innate hematoma resolution and neurological recovery after hemorrhagic stroke in mice	28
Extracellular vesicles derived from mesenchymal stem cells alleviate neuroinflammation and mechanical allodynia in interstitial cystitis rats by inhibiting NLRP3 inflammasome activation	28
Molecular mimicry of NMDA receptors may contribute to neuropsychiatric symptoms in severe COVID-19 cases	28
Oxygen therapy attenuates neuroinflammation after spinal cord injury	28
The role of CD56bright NK cells in neurodegenerative disorders	28
Anti-inflammatory role of GM1 and other gangliosides on microglia	28
Systemic inflammatory markers of persistent cerebral edema after aneurysmal subarachnoid hemorrhage	28
Fucoidan reduces NET accumulation and alleviates chemotherapy-induced peripheral neuropathy via the gut–blood–DRG axis	27
Astrocytic CXCL5 hinders microglial phagocytosis of myelin debris and aggravates white matter injury in chronic cerebral ischemia	27
Connexin 43 gap junction-mediated astrocytic network reconstruction attenuates isoflurane-induced cognitive dysfunction in mice	27
Single cell RNA sequencing after moderate traumatic brain injury: effects of therapeutic hypothermia	27
Using zebrafish to understand reciprocal interactions between the nervous and immune systems and the microbial world	27
Interleukin-2 improves insulin sensitivity through hypothalamic sympathetic activation in obese mice	27
Synaptic loss and progression in mice infected with Angiostrongylus cantonensis in the early stage	27
High-fat diet exacerbates cognitive decline in mouse models of Alzheimer's disease and mixed dementia in a sex-dependent manner	27
The protective PLCγ2-P522R variant mitigates Alzheimer’s disease-associated pathologies by enhancing beneficial microglial functions	27
AMPK-autophagy-mediated inhibition of microRNA-30a-5p alleviates morphine tolerance via SOCS3-dependent neuroinflammation suppression	27